{"cdcTestId":"2021-0005","testcaseName":"Patient is \u003C18 years and has received the Janssen Covid-19 vaccine","vaccineGroup":"COVID-19","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2006-10-19T00:00:00","gender":"M"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Janssen (J\u0026J) COVID-19 Vaccine","cvx":"212","mvx":"JSN","evaluationStatus":"Not Valid","evaluationReason":"Not a preferable or allowable vaccine"}]},"forecast":{"forecastNum":"1","earliestDate":"2022-11-16T00:00:00","recommendedDate":"2022-11-16T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Janssen (J\u0026J) COVID-19 Vaccine","cvx":"212","mvx":"JSN","evaluationStatus":"Not Valid","evaluationReason":"Not a preferable or allowable vaccine"}],"dateAdded":"2020-10-06T20:00:00","dateUpdated":"2022-08-25T09:00:09.137","generalDescription":"This test case describes when a patient that is less than 18 years of age and is administered the Janssen Covid-19 vaccine, that the dose is not valid.  Another age appropriate dose (preferably a mRNA) should be forecast.","changedInVersion":"4.26","reasonForChange":"v4.26 Updated vaccine dose status from \u0022valid\u0027 to \u0022not valid\u0022 based on current Covid-19 Clinical Consideration guidelines comments, found in Table C.\nv4.21 Updated past due date to 8 weeks per 02/22/22 Clinical Considerations guidelines\nv4.19 Updated the interval on the forecast dose to 28 days instead of 8 weeks per the Interim Clinical Considerations guidance concerning \u0022Unauthorized age group\u0022.\nv4.18 Updated the Forecast Earliest and Recommended dates that individuals should receive a booster dose at least 2 months ( 8 weeks) after a primary Janssen single dose.\nv4.17 Test case updated to reflect individuals 16 years and up can receive a booster dose (per updated clinical considerations on 12/10/21).\nv4.14  Test case updated to reflect that no additional doses should be forecast if patient is 16 and received a dose of the Janssen vaccine."}